Trijardy XR 12.5 mg/1 (Empagliflozin, Linagliptin, Metformin Hydrochloride TABLET, EXTENDED RELEASE) 12.5 mg/1

Trijardy XR 12.5 mg/1 combines empagliflozin, linagliptin, and metformin hydrochloride for blood sugar management. This extended-release tablet supports glycemic control in adults with type 2 diabetes. Learn about Trijardy XR uses, effects, and precautions.

Strength

12.5 mg/1

Pack Size

60 TABLET, EXTENDED RELEASE in 1 BOTTLE (0597-0385-77)

Manufacturer / TM Owner

Boehringer Ingelheim Pharmaceuticals, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Trijardy XR 12.5 mg/1 is designed to help manage blood sugar levels in adults with type 2 diabetes. This combination medication works by improving insulin sensitivity and reducing glucose absorption. People often ask, 'What is Trijardy XR used for?' It is typically prescribed as part of a broader diabetes management plan, including diet and exercise.

Side Effects

Common effects of Trijardy XR 12.5 mg/1 may include gastrointestinal discomfort, such as nausea or diarrhea, especially when first starting the medication. Some users may also experience urinary tract infections or hypoglycemia. These effects can vary and are not experienced by everyone.

Precautions & Warnings

Trijardy XR 12.5 mg/1 should be taken as directed by a healthcare provider. It is important to monitor blood sugar levels regularly and stay hydrated. This medication is not suitable for everyone, particularly those with severe kidney problems or a history of pancreatitis.

Avoid Interactions

Trijardy XR 12.5 mg/1 may interact with certain medications, including other diabetes drugs, diuretics, and some antibiotics. Alcohol can also affect blood sugar levels and should be consumed with caution. Always inform your healthcare provider about all medications you are taking.

Frequently Asked Questions

Trijardy XR 12.5 mg/1 is used to manage blood sugar levels in adults with type 2 diabetes.

Trijardy XR 12.5 mg/1 is an extended-release tablet taken orally, typically once daily with food.

Common side effects may include gastrointestinal discomfort, urinary tract infections, and hypoglycemia.

Trijardy XR 12.5 mg/1 may interact with other medications, so it is important to consult a healthcare provider.

Trijardy XR 12.5 mg/1 is not suitable for everyone, particularly those with severe kidney problems or a history of pancreatitis.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.